Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.48M Sell
213,921
-15,184
-7% -$271K ﹤0.01% 921
2026
Q1
$4.36M Sell
229,105
-67,954
-23% -$1.31M 0.01% 705
2025
Q4
$4.9M Sell
297,059
-322,190
-52% -$5.67M 0.01% 645
2025
Q3
$11.6M Sell
619,249
-56,080
-8% -$1.01M 0.01% 472
2025
Q2
$13.6M Buy
675,329
+312,045
+86% +$5.39M 0.02% 433
2025
Q1
$5M Buy
+363,284
New +$5M 0.01% 582
2024
Q2
Sell
-17,788
Closed -$456K 1643
2024
Q1
$456K Sell
17,788
-3,573
-17% -$89.6K ﹤0.01% 1041
2023
Q4
$557K Buy
21,361
+1,062
+5% +$24.2K ﹤0.01% 971
2023
Q3
$434K Buy
+20,299
New +$509K ﹤0.01% 1032

Other funds holding XP

Mackenzie Financial's XP Position: Q2 2026 in Review

Mackenzie Financial reduced its XP (XP) stake by 6.6% in Q2 2026, selling an estimated $271K and leaving 213,921 shares worth $3.48M. The position accounts for ﹤0.01% of the portfolio, ranked #921.

Mackenzie Financial first reported a position in XP in Q3 2023 and has held it in 9 quarters since. The position peaked at $13.6M in Q2 2025. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Mackenzie Financial held 213,921 shares of XP worth $3.48M as of Q2 2026.
  • Mackenzie Financial sold 15,184 XP shares in Q2 2026, an estimated $271K.
  • XP made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #921 holding.
  • Mackenzie Financial first reported a position in XP in Q3 2023 and has held it in 9 quarters since.
  • Mackenzie Financial's XP position peaked at $13.6M in Q2 2025.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.